Researchers overcome cellular defense barrier in self-amplifying mRNA vaccines

Source Summary

Scientists at Queen Mary University of London have developed a method to bypass cells' natural defenses against self-amplifying mRNA vaccines, enabling cells to produce substantially more target protein. The research, published in Nature Communications, addresses a key technical limitation in vaccine development.

Why it matters

Overcoming this cellular defense barrier could improve the efficacy and reduce the required dosage of self-amplifying mRNA vaccines, potentially broadening their therapeutic applications.